Prostate cancer
HRS-5041-103
A Phase I, Open-label, Multi-Center, Non-Randomized Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Caucasian Subjects with Metastatic Castration-resistant Prostate Cancer
Trial overview
Clinical Area
Medical Oncology
Disease
Prostate
Disease site
Genitourinary (GU)
Study Phase
I
Trial Identifiers
Registration number: NCT06830850
GenesisCare Location(s)
Principal Investigator(s)
Clinical trials enquiries